Project Grant H79SM090831
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Community Health Resources Inc. $800,000 on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532). Community Health Resources will implement the Zero Suicide framework across its behavioral health programs in north-central Connecticut, serving adults across a 20-town region. The project establishes...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) awarded Community Drug Board, Inc., doing business as CHC Addiction Services, $400,000 on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532). The Summit County Zero Suicide Project will implement a comprehensive zero suicide framework within a newly established federally qualified health center...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA Center for Mental Health Services) awarded University of Colorado Health $748,851 on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) to implement Zero Suicide at Scale, a systemwide initiative to strengthen suicide prevention across its Colorado healthcare network. University of Colorado Health will...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Mental Health Resource Center Inc. $742,512 on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) to expand the Zero Suicide framework across 11 behavioral health program sites serving seven Florida counties. The project implements standardized suicide risk screening, workforce training, suicide care...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $400,000 to Boston Health Care For The Homeless Program on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532). The recipient will implement the Zero Suicide Framework across its federally qualified health center and health care for the homeless program serving adults experiencing homelessness in Boston. The...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the Institute for Community Living Inc. $399,884 on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) to implement the Zero Suicide Initiative across its behavioral health continuum in New York City. ICL will strengthen suicide prevention for adults and young adults with serious mental illness and other...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded the Connecticut Department of Mental Health and Addiction Services $649,999 on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances program (CFDA 93.104) to operate the PRIME Clinic, a statewide early-psychosis detection and intervention program serving Connecticut youth aged 12–25 at clinical high risk for psychosis (CHR-P). The PRIME program...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $799,983 to Seattle Indian Health Board on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) to implement a five-year Zero Suicide Initiative strengthening agency-wide suicide prevention for adults in King County, Washington, with focus on American Indian and Alaska Native adults, veterans, individuals...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $798,271 to Upstate Cerebral Palsy, Inc. (doing business as Upstate Caring Partners) on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532). Upstate Caring Partners will implement the Zero Suicide Framework across its integrated crisis continuum in New York's Mohawk Valley, encompassing its certified...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the Child Health and Development Institute of Connecticut, Inc. $2.364 million on September 30, 2025, under the Center for Substance Abuse Prevention Projects of Regional and National Significance program (CFDA 93.492). Project Champion, a collaboration between the Child Health and Development Institute and three local health departments—Ledge Light Health District, Bristol-Burlington...
The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Community Health Center, Incorporated (CHCI) $799,872 under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) on September 30, 2026, to implement the Zero Suicide Framework across CHCI's statewide network of federally qualified health center sites in Connecticut. CHCI will expand workforce training, standardize suicide screening protocols, implement electronic health record procedures, and establish a comprehensive suicide care pathway supported by a dedicated suicide stabilization team and enhanced care coordination. The initiative serves more than 100,000 adult patients across CHCI's Connecticut locations and aims to improve identification, assessment, intervention, and follow-up for individuals at risk of suicide. Expected outcomes include increased screening and evidence-based care, stronger continuity of care, and reductions in suicidal ideation and suicide attempts. CHCI is executing the project in partnership with the Weitzman Institute and NAMI Connecticut. Performance will occur in Middletown, Connecticut, with a period of performance extending from September 30, 2026, through September 29, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $799.9k | 7/27/26 |